Events & Presentations
Upcoming Events
| Date | Event Details | Remind Me |
|---|---|---|
|
Jun 25, 2021
|
28th Annual FSHD Society International Research Congress
Jonathan Van Dyke, Ph.D., Arrowhead’s senior scientist II of biology, will deliver an oral presentation on the preclinical development of ARO-DUX4
|
Archived Events
| Date | Event Details |
|---|---|
|
Jun 23 - Jun 26, 2021
|
The International Liver Congress™ 2021 - The Annual Meeting of the European Association for the Study of the Liver (EASL)
Title: ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH Title: Short interfering RNA JNJ-3989 combination therapy in chronic hepatitis B shows potent reduction of all viral markers but no correlate was identified for HBsAg reduction and baseline factors Title: ARO-AAT an investigational RNAi therapeutic demonstrates improvement in liver fibrosis with reduction in intra-hepatic Z-AAT burden |
|
Jun 22, 2021
|
LifeSci Partners Genetic Medicines Summit 2021
Members of Arrowhead management will participate in a fireside chat presentation
|
|
Jun 17, 2021
|
Virtual Dana-Farber Harvard Cancer Center Symposium on HIF, VHL, and Kidney Cancer
View Presentation 903.8 KB
So Wong, Ph.D., Arrowhead’s senior director of biology, will deliver an oral presentation on the preclinical development of ARO-HIF2
|
|
Jun 12, 2021
|
2021 Virtual Alpha-1 National Conference
View Presentation 678.5 KB
Javier San Martin, M.D., Arrowhead’s chief medical officer, will deliver an oral presentation
|
|
Jun 10, 2021 2:10 PM EDT
|
Goldman Sachs 42nd Annual Global Healthcare Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
|
|
Jun 3, 2021 2:30 PM EDT
|
Jefferies Virtual Healthcare Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
|
|
May 26, 2021 3:00 PM EDT
|
UBS Global Healthcare Virtual Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
|
|
May 18, 2021 11:30 AM EDT
|
2021 RBC Capital Markets Global Healthcare
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
|
|
May 4, 2021 4:30 PM EDT
|
Arrowhead Pharmaceuticals 2021 Second Quarter Results
Prepared Remarks 202.1 KB
|
|
Feb 4, 2021 4:30 PM EST
|
Arrowhead Pharmaceuticals 2021 First Quarter Results
|